Related Articles
FISH testing of HER2 immunohistochemistry 1+ invasive breast cancer with unfavorable characteristics
Breast cancers with EGFR and HER2 co‑amplification favor distant metastasis and poor clinical outcome
HPK1 positive expression associated with longer overall survival in patients with estrogen receptor-positive invasive ductal carcinoma‑not otherwise specified
ERBB2 and PTPN2 gene copy numbers as prognostic factors in HER2‑positive metastatic breast cancer treated with trastuzumab
Detection of Her2/neu, c-MYC and ZNF217 gene amplification during breast cancer progression using fluorescence in situ hybridization